Safety and Efficacy of BKM120 in Relapsed and Refractory NHL

Update Il y a 5 ans
Reference: NCT01693614

Woman and Man

Extract

This is a phase II study evaluating the safety, tolerability and efficacy of BKM120 in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL) or follicular lymphoma (FL).


Inclusion criteria

  • Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma


Links